Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 44 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2004Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicityColler, J.; Krebsfaenger, N.; Klein, K.; Wolbold, R.; Nussler, A.; Neuhaus, P.; Zanger, U.; Eichelbaum, M.; Murdter, T.
2012Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patientsColler, J.; Michalakas, J.; James, H.; Farquharson, A.; Colvill, J.; White, J.; Somogyi, A.
2009Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRMI) and opioid defendence: A meta-analysisColler, J.; Beardsley, J.; Bignold, J.; Li, Y.; Merg, F.; Sullivan, T.; Cox, T.; Somogyi, A.
2012Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjectsGelston, E.; Coller, J.; Lopatko, O.; James, H.; Schmidt, H.; White, J.; Somogyi, A.
1999Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4Coller, J.; Somogyi, A.; Bochner, F.
1999Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.Coller, J.; Somogyi, A.; Bochner, F.
1997Association between CYP2C19 genotype and proguanil oxidative polymorphism.Coller, J.; Somogyi, A.; Bochner, F.
2008Pharmacogenomics and PharmacogeneticsSomogyi, A.; Coller, J.
2001Distribution of microsomal epoxide hydrolase in humans: An immunohistochemical study in normal tissues, and benign and malignant tumoursColler, J.; Fritz, P.; Zanger, U.; Siegle, I.; Eichelbaum, M.; Kroemer, H.; Murdter, T.
2001Sensitive and rapid quantification of busulfan in small plasma volumes by liquid chromatography-electrospray mass spectrometryMurdter, T.; Coller, J.; Claviez, A.; Schonberger, F.; Hofmann, U.; Dreger, P.; Schwab, M.